Anamika Basu

Affiliations: 
Loma Linda University, Loma Linda, United States 
Google:
"Anamika Basu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Durán AM, Salto LM, Câmara J, et al. (2019) Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 12: 109-120
Woods-Burnham L, Cajigas-Du Ross CK, Love A, et al. (2018) Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Scientific Reports. 8: 15063
Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, et al. (2018) RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9: 30363-30384
Woods-Burnham L, Basu A, Cajigas-Du Ross CK, et al. (2017) The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. The Prostate
Ríos-Colón L, Cajigas-Du Ross CK, Basu A, et al. (2017) Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget
Mercado MV, Gómez-Bañuelos E, Navarro-Hernández RE, et al. (2017) Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms. Auto- Immunity Highlights. 8: 1
Basu A, Cajigas-Du Ross CK, Rios-Colon L, et al. (2016) LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. Plos One. 11: e0146549
Basu A, Woods-Burnham L, Ortiz G, et al. (2015) Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clinical Immunology (Orlando, Fla.). 161: 241-250
Ochs RL, Mahler M, Basu A, et al. (2015) The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clinical and Experimental Medicine
Basu A, Sanchez TW, Casiano CA. (2015) DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer. Frontiers in Immunology. 6: 116
See more...